BC
BMY icon

Bridgefront Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bridgefront Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,011
Closed -$270K – 538
2025
Q4 		$270K Sell
5,011
-28,393
-85% -$1.37M 0.07% 395
2025
Q3 		$1.51M Buy
33,404
+11,315
+51% +$528K 0.44% 31
2025
Q2 		$1.02M Buy
+22,089
New +$1.08M 0.27% 92
2024
Q4 		– Sell
-21,836
Closed -$1.13M – 593
2024
Q3 		$1.13M Sell
21,836
-592
-3% -$27.8K 0.44% 37
2024
Q2 		$931K Buy
+22,428
New +$1M 0.39% 57
2024
Q1 		– Sell
-5,215
Closed -$268K – 387
2023
Q4 		$268K Sell
5,215
-1,972
-27% -$104K 0.2% 199
2023
Q3 		$417K Sell
7,187
-13,747
-66% -$842K 0.29% 112
2023
Q2 		$1.34M Buy
+20,934
New +$1.4M 0.72% 7
2023
Q1 		– Sell
-7,589
Closed -$546K – 425
2022
Q4 		$546K Buy
+7,589
New +$572K 0.38% 78
2022
Q1 		– Sell
-4,599
Closed -$287K – 281
2021
Q4 		$287K Buy
+4,599
New +$270K 0.28% 153
2021
Q3 		– Sell
-16,186
Closed -$1.08M – 356
2021
Q2 		$1.08M Buy
16,186
+9,603
+146% +$626K 0.41% 39
2021
Q1 		$416K Sell
6,583
-6,907
-51% -$430K 0.13% 307
2020
Q4 		$837K Buy
+13,490
New +$829K 0.29% 87

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bridgefront Capital's BMY Position: Q1 2026 in Review

Bridgefront Capital sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 5,011 shares — an estimated $270K sold.

Bridgefront Capital first reported a position in BMY in Q4 2020 and held it in 13 quarters. The position peaked at $1.51M in Q3 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Bridgefront Capital reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Bridgefront Capital sold 5,011 Bristol-Myers Squibb shares in Q1 2026, an estimated $270K.
  • Bridgefront Capital first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 13 quarters.
  • Bridgefront Capital's Bristol-Myers Squibb position peaked at $1.51M in Q3 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.